Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study
Identifieur interne : 000740 ( Istex/Corpus ); précédent : 000739; suivant : 000741Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study
Auteurs : Jang-Jaer Lee ; Shih-Jung Cheng ; Jai-Jen Wang ; Chun-Pin Chiang ; Hao-Hueng Chang ; Hsin-Ming Chen ; Sang-Heng KokSource :
- Head & Neck [ 1043-3074 ] ; 2013-12.
English descriptors
- KwdEn :
- Adjunctive therapy, Alcohol drinking, Alendronate, Alendronate therapy, Alkaline phosphatase, American association, Anterior lesion length, Anterior lesions, Better prognosis, Biochemical markers, Bisphosphonate, Bisphosphonate treatment, Bisphosphonaterelated osteonecrosis, Bisphosphonates, Bone destruction area, Bone formation, Bone mineral density, Bone necrosis, Bone resorption, Bone turnover, Bronj, Bronj diagnosis, Bronj lesions, Bronj patients, Bsap, Bsap level, Bsap levels, Cancer chemotherapy, Cancer patients, Certain period, Chlorhexidine mouth rinse, Clinical factors, Clinical variables, Complete response, Confidence interval, Cumulative dose, December, Deeper extension, Diabetes mellitus, Disease stage, Drug holiday, Drug therapy, Drug treatment, Event dentoalveolar surgery, Hazard ratio, Head december, Head neck, Healing period, Healing time, Higher pretreatment level, Intravenous bisphosphonates, Lesion, Lesion depth, Lesion length, Lesion resolution, Lesion site lesion depth, Lesion site maxilla mandible lesion site, Mandible, Maxillofac, Maxillofacial surgeons, Maxillofacial surgery, Median, Medical comorbidities, Multivariate analyses, Multivariate analysis, National taiwan university, National taiwan university hospital, Oral alendronate, Oral bisphosphonate, Oral bisphosphonate therapy, Oral bisphosphonates, Oral maxillofac surg, Oral oncol, Oral pathol, Oral surg, Osteonecrosis, Osteoporosis, Osteoporotic, Osteoporotic patients, Parathyroid hormone, Pathologic fracture, Pearson correlation coefficient, Phosphatase, Postmenopausal osteoporosis, Postmenopausal women, Present study, Pretreatment, Pretreatment serum bsap, Previous studies, Prognosis, Prognostic, Prognostic figure, Prognostic indicators, Prognostic values, Radiol endod, Risk factors, Serum bsap, Serum bsap level, Serum level, Serum markers, Significant difference, Surg, Surgical, Surgical therapy, Surgical treatment, Teriparatide, Treatment modalities, Treatment outcome, Treatment outcomes, Treatment period, True extent, Turnover, Uninvolved bone.
- Teeft :
- Adjunctive therapy, Alcohol drinking, Alendronate, Alendronate therapy, Alkaline phosphatase, American association, Anterior lesion length, Anterior lesions, Better prognosis, Biochemical markers, Bisphosphonate, Bisphosphonate treatment, Bisphosphonaterelated osteonecrosis, Bisphosphonates, Bone destruction area, Bone formation, Bone mineral density, Bone necrosis, Bone resorption, Bone turnover, Bronj, Bronj diagnosis, Bronj lesions, Bronj patients, Bsap, Bsap level, Bsap levels, Cancer chemotherapy, Cancer patients, Certain period, Chlorhexidine mouth rinse, Clinical factors, Clinical variables, Complete response, Confidence interval, Cumulative dose, December, Deeper extension, Diabetes mellitus, Disease stage, Drug holiday, Drug therapy, Drug treatment, Event dentoalveolar surgery, Hazard ratio, Head december, Head neck, Healing period, Healing time, Higher pretreatment level, Intravenous bisphosphonates, Lesion, Lesion depth, Lesion length, Lesion resolution, Lesion site lesion depth, Lesion site maxilla mandible lesion site, Mandible, Maxillofac, Maxillofacial surgeons, Maxillofacial surgery, Median, Medical comorbidities, Multivariate analyses, Multivariate analysis, National taiwan university, National taiwan university hospital, Oral alendronate, Oral bisphosphonate, Oral bisphosphonate therapy, Oral bisphosphonates, Oral maxillofac surg, Oral oncol, Oral pathol, Oral surg, Osteonecrosis, Osteoporosis, Osteoporotic, Osteoporotic patients, Parathyroid hormone, Pathologic fracture, Pearson correlation coefficient, Phosphatase, Postmenopausal osteoporosis, Postmenopausal women, Present study, Pretreatment, Pretreatment serum bsap, Previous studies, Prognosis, Prognostic, Prognostic figure, Prognostic indicators, Prognostic values, Radiol endod, Risk factors, Serum bsap, Serum bsap level, Serum level, Serum markers, Significant difference, Surg, Surgical, Surgical therapy, Surgical treatment, Teriparatide, Treatment modalities, Treatment outcome, Treatment outcomes, Treatment period, True extent, Turnover, Uninvolved bone.
Abstract
Studies concerning prognostic factors specific for alendronate‐related osteonecrosis of the jaws (ONJ) are rare.
Url:
DOI: 10.1002/hed.23235
Links to Exploration step
ISTEX:C2C0B6B18F602D840DB14B1C94225B43303DF96ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study</title><author><name sortKey="Lee, Jang Aer" sort="Lee, Jang Aer" uniqKey="Lee J" first="Jang-Jaer" last="Lee">Jang-Jaer Lee</name><affiliation><mods:affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</mods:affiliation></affiliation></author><author><name sortKey="Cheng, Shih Ung" sort="Cheng, Shih Ung" uniqKey="Cheng S" first="Shih-Jung" last="Cheng">Shih-Jung Cheng</name><affiliation><mods:affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</mods:affiliation></affiliation></author><author><name sortKey="Wang, Jai En" sort="Wang, Jai En" uniqKey="Wang J" first="Jai-Jen" last="Wang">Jai-Jen Wang</name><affiliation><mods:affiliation>Department of Finance, Feng Chia University, Taichung, Taiwan</mods:affiliation></affiliation></author><author><name sortKey="Chiang, Chun In" sort="Chiang, Chun In" uniqKey="Chiang C" first="Chun-Pin" last="Chiang">Chun-Pin Chiang</name><affiliation><mods:affiliation>Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</mods:affiliation></affiliation></author><author><name sortKey="Chang, Hao Ueng" sort="Chang, Hao Ueng" uniqKey="Chang H" first="Hao-Hueng" last="Chang">Hao-Hueng Chang</name><affiliation><mods:affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</mods:affiliation></affiliation></author><author><name sortKey="Chen, Hsin Ing" sort="Chen, Hsin Ing" uniqKey="Chen H" first="Hsin-Ming" last="Chen">Hsin-Ming Chen</name><affiliation><mods:affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</mods:affiliation></affiliation></author><author><name sortKey="Kok, Sang Eng" sort="Kok, Sang Eng" uniqKey="Kok S" first="Sang-Heng" last="Kok">Sang-Heng Kok</name><affiliation><mods:affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: shkok@ntu.edu.tw</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:C2C0B6B18F602D840DB14B1C94225B43303DF96E</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1002/hed.23235</idno><idno type="url">https://api.istex.fr/document/C2C0B6B18F602D840DB14B1C94225B43303DF96E/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000740</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000740</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study</title><author><name sortKey="Lee, Jang Aer" sort="Lee, Jang Aer" uniqKey="Lee J" first="Jang-Jaer" last="Lee">Jang-Jaer Lee</name><affiliation><mods:affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</mods:affiliation></affiliation></author><author><name sortKey="Cheng, Shih Ung" sort="Cheng, Shih Ung" uniqKey="Cheng S" first="Shih-Jung" last="Cheng">Shih-Jung Cheng</name><affiliation><mods:affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</mods:affiliation></affiliation></author><author><name sortKey="Wang, Jai En" sort="Wang, Jai En" uniqKey="Wang J" first="Jai-Jen" last="Wang">Jai-Jen Wang</name><affiliation><mods:affiliation>Department of Finance, Feng Chia University, Taichung, Taiwan</mods:affiliation></affiliation></author><author><name sortKey="Chiang, Chun In" sort="Chiang, Chun In" uniqKey="Chiang C" first="Chun-Pin" last="Chiang">Chun-Pin Chiang</name><affiliation><mods:affiliation>Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</mods:affiliation></affiliation></author><author><name sortKey="Chang, Hao Ueng" sort="Chang, Hao Ueng" uniqKey="Chang H" first="Hao-Hueng" last="Chang">Hao-Hueng Chang</name><affiliation><mods:affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</mods:affiliation></affiliation></author><author><name sortKey="Chen, Hsin Ing" sort="Chen, Hsin Ing" uniqKey="Chen H" first="Hsin-Ming" last="Chen">Hsin-Ming Chen</name><affiliation><mods:affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</mods:affiliation></affiliation></author><author><name sortKey="Kok, Sang Eng" sort="Kok, Sang Eng" uniqKey="Kok S" first="Sang-Heng" last="Kok">Sang-Heng Kok</name><affiliation><mods:affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: shkok@ntu.edu.tw</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Head & Neck</title><title level="j" type="alt">HEAD AND NECK</title><idno type="ISSN">1043-3074</idno><idno type="eISSN">1097-0347</idno><imprint><biblScope unit="vol">35</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="1787">1787</biblScope><biblScope unit="page" to="1795">1795</biblScope><biblScope unit="page-count">9</biblScope><date type="published" when="2013-12">2013-12</date></imprint><idno type="ISSN">1043-3074</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1043-3074</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adjunctive therapy</term><term>Alcohol drinking</term><term>Alendronate</term><term>Alendronate therapy</term><term>Alkaline phosphatase</term><term>American association</term><term>Anterior lesion length</term><term>Anterior lesions</term><term>Better prognosis</term><term>Biochemical markers</term><term>Bisphosphonate</term><term>Bisphosphonate treatment</term><term>Bisphosphonaterelated osteonecrosis</term><term>Bisphosphonates</term><term>Bone destruction area</term><term>Bone formation</term><term>Bone mineral density</term><term>Bone necrosis</term><term>Bone resorption</term><term>Bone turnover</term><term>Bronj</term><term>Bronj diagnosis</term><term>Bronj lesions</term><term>Bronj patients</term><term>Bsap</term><term>Bsap level</term><term>Bsap levels</term><term>Cancer chemotherapy</term><term>Cancer patients</term><term>Certain period</term><term>Chlorhexidine mouth rinse</term><term>Clinical factors</term><term>Clinical variables</term><term>Complete response</term><term>Confidence interval</term><term>Cumulative dose</term><term>December</term><term>Deeper extension</term><term>Diabetes mellitus</term><term>Disease stage</term><term>Drug holiday</term><term>Drug therapy</term><term>Drug treatment</term><term>Event dentoalveolar surgery</term><term>Hazard ratio</term><term>Head december</term><term>Head neck</term><term>Healing period</term><term>Healing time</term><term>Higher pretreatment level</term><term>Intravenous bisphosphonates</term><term>Lesion</term><term>Lesion depth</term><term>Lesion length</term><term>Lesion resolution</term><term>Lesion site lesion depth</term><term>Lesion site maxilla mandible lesion site</term><term>Mandible</term><term>Maxillofac</term><term>Maxillofacial surgeons</term><term>Maxillofacial surgery</term><term>Median</term><term>Medical comorbidities</term><term>Multivariate analyses</term><term>Multivariate analysis</term><term>National taiwan university</term><term>National taiwan university hospital</term><term>Oral alendronate</term><term>Oral bisphosphonate</term><term>Oral bisphosphonate therapy</term><term>Oral bisphosphonates</term><term>Oral maxillofac surg</term><term>Oral oncol</term><term>Oral pathol</term><term>Oral surg</term><term>Osteonecrosis</term><term>Osteoporosis</term><term>Osteoporotic</term><term>Osteoporotic patients</term><term>Parathyroid hormone</term><term>Pathologic fracture</term><term>Pearson correlation coefficient</term><term>Phosphatase</term><term>Postmenopausal osteoporosis</term><term>Postmenopausal women</term><term>Present study</term><term>Pretreatment</term><term>Pretreatment serum bsap</term><term>Previous studies</term><term>Prognosis</term><term>Prognostic</term><term>Prognostic figure</term><term>Prognostic indicators</term><term>Prognostic values</term><term>Radiol endod</term><term>Risk factors</term><term>Serum bsap</term><term>Serum bsap level</term><term>Serum level</term><term>Serum markers</term><term>Significant difference</term><term>Surg</term><term>Surgical</term><term>Surgical therapy</term><term>Surgical treatment</term><term>Teriparatide</term><term>Treatment modalities</term><term>Treatment outcome</term><term>Treatment outcomes</term><term>Treatment period</term><term>True extent</term><term>Turnover</term><term>Uninvolved bone</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>Adjunctive therapy</term><term>Alcohol drinking</term><term>Alendronate</term><term>Alendronate therapy</term><term>Alkaline phosphatase</term><term>American association</term><term>Anterior lesion length</term><term>Anterior lesions</term><term>Better prognosis</term><term>Biochemical markers</term><term>Bisphosphonate</term><term>Bisphosphonate treatment</term><term>Bisphosphonaterelated osteonecrosis</term><term>Bisphosphonates</term><term>Bone destruction area</term><term>Bone formation</term><term>Bone mineral density</term><term>Bone necrosis</term><term>Bone resorption</term><term>Bone turnover</term><term>Bronj</term><term>Bronj diagnosis</term><term>Bronj lesions</term><term>Bronj patients</term><term>Bsap</term><term>Bsap level</term><term>Bsap levels</term><term>Cancer chemotherapy</term><term>Cancer patients</term><term>Certain period</term><term>Chlorhexidine mouth rinse</term><term>Clinical factors</term><term>Clinical variables</term><term>Complete response</term><term>Confidence interval</term><term>Cumulative dose</term><term>December</term><term>Deeper extension</term><term>Diabetes mellitus</term><term>Disease stage</term><term>Drug holiday</term><term>Drug therapy</term><term>Drug treatment</term><term>Event dentoalveolar surgery</term><term>Hazard ratio</term><term>Head december</term><term>Head neck</term><term>Healing period</term><term>Healing time</term><term>Higher pretreatment level</term><term>Intravenous bisphosphonates</term><term>Lesion</term><term>Lesion depth</term><term>Lesion length</term><term>Lesion resolution</term><term>Lesion site lesion depth</term><term>Lesion site maxilla mandible lesion site</term><term>Mandible</term><term>Maxillofac</term><term>Maxillofacial surgeons</term><term>Maxillofacial surgery</term><term>Median</term><term>Medical comorbidities</term><term>Multivariate analyses</term><term>Multivariate analysis</term><term>National taiwan university</term><term>National taiwan university hospital</term><term>Oral alendronate</term><term>Oral bisphosphonate</term><term>Oral bisphosphonate therapy</term><term>Oral bisphosphonates</term><term>Oral maxillofac surg</term><term>Oral oncol</term><term>Oral pathol</term><term>Oral surg</term><term>Osteonecrosis</term><term>Osteoporosis</term><term>Osteoporotic</term><term>Osteoporotic patients</term><term>Parathyroid hormone</term><term>Pathologic fracture</term><term>Pearson correlation coefficient</term><term>Phosphatase</term><term>Postmenopausal osteoporosis</term><term>Postmenopausal women</term><term>Present study</term><term>Pretreatment</term><term>Pretreatment serum bsap</term><term>Previous studies</term><term>Prognosis</term><term>Prognostic</term><term>Prognostic figure</term><term>Prognostic indicators</term><term>Prognostic values</term><term>Radiol endod</term><term>Risk factors</term><term>Serum bsap</term><term>Serum bsap level</term><term>Serum level</term><term>Serum markers</term><term>Significant difference</term><term>Surg</term><term>Surgical</term><term>Surgical therapy</term><term>Surgical treatment</term><term>Teriparatide</term><term>Treatment modalities</term><term>Treatment outcome</term><term>Treatment outcomes</term><term>Treatment period</term><term>True extent</term><term>Turnover</term><term>Uninvolved bone</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract">Studies concerning prognostic factors specific for alendronate‐related osteonecrosis of the jaws (ONJ) are rare.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>bronj</json:string><json:string>osteonecrosis</json:string><json:string>bsap</json:string><json:string>alendronate</json:string><json:string>bisphosphonates</json:string><json:string>lesion</json:string><json:string>prognostic</json:string><json:string>surg</json:string><json:string>maxillofac</json:string><json:string>bisphosphonate</json:string><json:string>oral maxillofac surg</json:string><json:string>mandible</json:string><json:string>december</json:string><json:string>teriparatide</json:string><json:string>osteoporotic</json:string><json:string>pretreatment</json:string><json:string>bone turnover</json:string><json:string>osteoporosis</json:string><json:string>lesion depth</json:string><json:string>head december</json:string><json:string>bronj lesions</json:string><json:string>osteoporotic patients</json:string><json:string>phosphatase</json:string><json:string>treatment period</json:string><json:string>treatment outcome</json:string><json:string>complete response</json:string><json:string>prognostic indicators</json:string><json:string>serum markers</json:string><json:string>risk factors</json:string><json:string>bsap level</json:string><json:string>alkaline phosphatase</json:string><json:string>present study</json:string><json:string>prognosis</json:string><json:string>pathologic fracture</json:string><json:string>biochemical markers</json:string><json:string>bone formation</json:string><json:string>intravenous bisphosphonates</json:string><json:string>bsap levels</json:string><json:string>serum bsap level</json:string><json:string>national taiwan university hospital</json:string><json:string>surgical</json:string><json:string>turnover</json:string><json:string>median</json:string><json:string>cancer patients</json:string><json:string>maxillofacial surgeons</json:string><json:string>multivariate analysis</json:string><json:string>hazard ratio</json:string><json:string>oral alendronate</json:string><json:string>bone mineral density</json:string><json:string>disease stage</json:string><json:string>alendronate therapy</json:string><json:string>lesion site lesion depth</json:string><json:string>healing period</json:string><json:string>previous studies</json:string><json:string>anterior lesions</json:string><json:string>oral bisphosphonate therapy</json:string><json:string>parathyroid hormone</json:string><json:string>better prognosis</json:string><json:string>confidence interval</json:string><json:string>drug holiday</json:string><json:string>oral surg</json:string><json:string>oral pathol</json:string><json:string>radiol endod</json:string><json:string>bronj diagnosis</json:string><json:string>bone resorption</json:string><json:string>multivariate analyses</json:string><json:string>maxillofacial surgery</json:string><json:string>diabetes mellitus</json:string><json:string>cancer chemotherapy</json:string><json:string>bronj patients</json:string><json:string>american association</json:string><json:string>higher pretreatment level</json:string><json:string>pretreatment serum bsap</json:string><json:string>postmenopausal osteoporosis</json:string><json:string>significant difference</json:string><json:string>alcohol drinking</json:string><json:string>pearson correlation coefficient</json:string><json:string>lesion site maxilla mandible lesion site</json:string><json:string>anterior lesion length</json:string><json:string>event dentoalveolar surgery</json:string><json:string>bone necrosis</json:string><json:string>oral bisphosphonates</json:string><json:string>clinical variables</json:string><json:string>prognostic figure</json:string><json:string>lesion length</json:string><json:string>surgical treatment</json:string><json:string>surgical therapy</json:string><json:string>lesion resolution</json:string><json:string>bone destruction area</json:string><json:string>head neck</json:string><json:string>postmenopausal women</json:string><json:string>true extent</json:string><json:string>cumulative dose</json:string><json:string>drug therapy</json:string><json:string>certain period</json:string><json:string>oral bisphosphonate</json:string><json:string>clinical factors</json:string><json:string>national taiwan university</json:string><json:string>adjunctive therapy</json:string><json:string>serum bsap</json:string><json:string>healing time</json:string><json:string>prognostic values</json:string><json:string>chlorhexidine mouth rinse</json:string><json:string>drug treatment</json:string><json:string>oral oncol</json:string><json:string>treatment outcomes</json:string><json:string>uninvolved bone</json:string><json:string>medical comorbidities</json:string><json:string>treatment modalities</json:string><json:string>bisphosphonaterelated osteonecrosis</json:string><json:string>bisphosphonate treatment</json:string><json:string>deeper extension</json:string><json:string>serum level</json:string></teeft></keywords><author><json:item><name>Jang‐Jaer Lee DDS, MS</name><affiliations><json:string>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</json:string></affiliations></json:item><json:item><name>Shih‐Jung Cheng DDS, MS, PhD</name><affiliations><json:string>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</json:string></affiliations></json:item><json:item><name>Jai‐Jen Wang BA, MA, PhD</name><affiliations><json:string>Department of Finance, Feng Chia University, Taichung, Taiwan</json:string></affiliations></json:item><json:item><name>Chun‐Pin Chiang DDS, DMSc</name><affiliations><json:string>Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</json:string></affiliations></json:item><json:item><name>Hao‐Hueng Chang DDS, MS, PhD</name><affiliations><json:string>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</json:string></affiliations></json:item><json:item><name>Hsin‐Ming Chen DDS, MS, PhD</name><affiliations><json:string>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</json:string></affiliations></json:item><json:item><name>Sang‐Heng Kok DDS, PhD</name><affiliations><json:string>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</json:string><json:string>E-mail: shkok@ntu.edu.tw</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>osteoporosis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>alendronate</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>ONJ</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>CTX</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>BSAP</value></json:item></subject><articleId><json:string>HED23235</json:string></articleId><arkIstex>ark:/67375/WNG-GM5TSDTZ-V</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>Studies concerning prognostic factors specific for alendronate‐related osteonecrosis of the jaws (ONJ) are rare.</abstract><qualityIndicators><score>7.168</score><pdfWordCount>5661</pdfWordCount><pdfCharCount>38029</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>9</pdfPageCount><pdfPageSize>612 x 809.972 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractWordCount>14</abstractWordCount><abstractCharCount>112</abstractCharCount><keywordCount>5</keywordCount></qualityIndicators><title>Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study</title><pmid><json:string>23508560</json:string></pmid><genre><json:string>article</json:string></genre><host><title>Head & Neck</title><language><json:string>unknown</json:string></language><doi><json:string>10.1002/(ISSN)1097-0347</json:string></doi><issn><json:string>1043-3074</json:string></issn><eissn><json:string>1097-0347</json:string></eissn><publisherId><json:string>HED</json:string></publisherId><volume>35</volume><issue>12</issue><pages><first>1787</first><last>1795</last><total>9</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Original Article</value></json:item></subject></host><namedEntities><unitex><date><json:string>DECEMBER 2013 1793</json:string><json:string>5100</json:string><json:string>2013-11-13</json:string><json:string>DECEMBER 2013 1787</json:string><json:string>2013</json:string><json:string>between January 2008 and December 2011</json:string><json:string>DECEMBER 2013 1789</json:string><json:string>DECEMBER 2013 1791</json:string></date><geogName><json:string>AHR</json:string></geogName><orgName><json:string>SPSS Inc., Chicago</json:string><json:string>Roche Diagnostics</json:string><json:string>AAOMS</json:string><json:string>Research Ethics Committee of the National Taiwan University Hospital</json:string><json:string>American Association of Oral and Maxillofacial Surgeons</json:string><json:string>Department of Dentistry, National Taiwan University Hospital, Taipei, Taiwan</json:string><json:string>Beckman Coulter, Inc.</json:string><json:string>Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</json:string><json:string>American Association of Oral and Maxillofacial Surgeons (AAOMS)</json:string><json:string>Wiley Periodicals, Inc</json:string><json:string>Department of Finance, Feng Chia University, Taichung, Taiwan</json:string><json:string>National Taiwan University Hospital</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>H. Kok</json:string><json:string>Ming Chen</json:string></persName><placeName><json:string>Germany</json:string><json:string>Denmark</json:string><json:string>Chaska</json:string><json:string>MN</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>Stanton et al</json:string><json:string>Kwon et al</json:string><json:string>Scoletta et al</json:string><json:string>Marx et al.</json:string><json:string>Van der Wyngaert et al</json:string><json:string>Scoletta et al.</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-GM5TSDTZ-V</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - surgery</json:string><json:string>2 - otorhinolaryngology</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - otorhinolaryngology</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Otorhinolaryngology</json:string></scopus></categories><publicationDate>2013</publicationDate><copyrightDate>2013</copyrightDate><doi><json:string>10.1002/hed.23235</json:string></doi><id>C2C0B6B18F602D840DB14B1C94225B43303DF96E</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/C2C0B6B18F602D840DB14B1C94225B43303DF96E/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/C2C0B6B18F602D840DB14B1C94225B43303DF96E/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/C2C0B6B18F602D840DB14B1C94225B43303DF96E/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Publishing Ltd</publisher><availability><licence>Copyright © 2013 Wiley Periodicals, Inc., A Wiley Company</licence></availability><date type="published" when="2013-12"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study</title><title level="a" type="short">Prognostic Factors of Alendronate‐Related Osteonecrosis of Jaws</title><author xml:id="author-0000"><persName><forename type="first">Jang‐Jaer</forename><surname>Lee</surname><roleName type="degree">DDS, MS</roleName></persName><affiliation><orgName>School of Dentistry</orgName><orgName>National Taiwan University Medical Center</orgName><address><settlement type="city">Taipei</settlement><country key="TW">Taiwan</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">Shih‐Jung</forename><surname>Cheng</surname><roleName type="degree">DDS, MS, PhD</roleName></persName><affiliation><orgName>School of Dentistry</orgName><orgName>National Taiwan University Medical Center</orgName><address><settlement type="city">Taipei</settlement><country key="TW">Taiwan</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">Jai‐Jen</forename><surname>Wang</surname><roleName type="degree">BA, MA, PhD</roleName></persName><affiliation><orgName>Department of Finance</orgName><orgName>Feng Chia University</orgName><address><settlement type="city">Taichung</settlement><country key="TW">Taiwan</country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">Chun‐Pin</forename><surname>Chiang</surname><roleName type="degree">DDS, DMSc</roleName></persName><affiliation><orgName>Graduate Institute of Oral Biology</orgName><orgName>School of Dentistry</orgName><orgName>National Taiwan University Medical Center</orgName><address><settlement type="city">Taipei</settlement><country key="TW">Taiwan</country></address></affiliation></author><author xml:id="author-0004"><persName><forename type="first">Hao‐Hueng</forename><surname>Chang</surname><roleName type="degree">DDS, MS, PhD</roleName></persName><affiliation><orgName>School of Dentistry</orgName><orgName>National Taiwan University Medical Center</orgName><address><settlement type="city">Taipei</settlement><country key="TW">Taiwan</country></address></affiliation></author><author xml:id="author-0005"><persName><forename type="first">Hsin‐Ming</forename><surname>Chen</surname><roleName type="degree">DDS, MS, PhD</roleName></persName><affiliation><orgName>School of Dentistry</orgName><orgName>National Taiwan University Medical Center</orgName><address><settlement type="city">Taipei</settlement><country key="TW">Taiwan</country></address></affiliation></author><author xml:id="author-0006" role="corresp"><persName><forename type="first">Sang‐Heng</forename><surname>Kok</surname><roleName type="degree">DDS, PhD</roleName></persName><affiliation><orgName>School of Dentistry</orgName><orgName>National Taiwan University Medical Center</orgName><address><settlement type="city">Taipei</settlement><country key="TW">Taiwan</country></address></affiliation><affiliation>Corresponding author: S.‐H. Kok, Department of Dentistry, National Taiwan University Hospital, Taipei, Taiwan 10016. E‐mail: shkok@ntu.edu.tw</affiliation></author><idno type="istex">C2C0B6B18F602D840DB14B1C94225B43303DF96E</idno><idno type="ark">ark:/67375/WNG-GM5TSDTZ-V</idno><idno type="DOI">10.1002/hed.23235</idno><idno type="unit">HED23235</idno><idno type="toTypesetVersion">file:HED.HED23235.pdf</idno></analytic><monogr><title level="j" type="main">Head & Neck</title><title level="j" type="alt">HEAD AND NECK</title><idno type="pISSN">1043-3074</idno><idno type="eISSN">1097-0347</idno><idno type="book-DOI">10.1002/(ISSN)1097-0347</idno><idno type="book-part-DOI">10.1002/hed.v35.12</idno><idno type="product">HED</idno><imprint><biblScope unit="vol">35</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="1787">1787</biblScope><biblScope unit="page" to="1795">1795</biblScope><biblScope unit="page-count">9</biblScope><date type="published" when="2013-12"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><abstract style="main">
Background
<p>Studies concerning prognostic factors specific for alendronate‐related osteonecrosis of the jaws (ONJ) are rare.</p>
Methods
<p>We surveyed a cohort of 100 osteoporotic patients with 111 alendronate‐related ONJ lesions treated during a 4‐year period. Prognostic values of clinical variables and serum markers of bone turnover were assessed by univariate and multivariate analyses.</p>
Results
<p>The cumulative complete response rate at 6 months was 48.65%. Serum bone‐specific alkaline phosphatase (BSAP) level >10 μg/L, lesion depth ≦ 10 mm, and lesions in anterior regions denoted a better chance of healing within 6 months and the adjusted hazard ratios were 2.48 (95% confidence interval [CI], 1.41–4.37), 2.71 (95% CI, 1.57–4.70), and 3.94 (95% CI, 1.87–8.30), respectively.</p>
Conclusions
<p>Early discovery of lesions and prevention of their deeper extension are crucial for improving the prognosis of alendronate‐related ONJ. A higher pretreatment level of BSAP indicates a better prognosis. © 2013 Wiley Periodicals, Inc. <hi rend="italic">Head Neck</hi> 35: 1787–1795, 2013</p></abstract><textClass><keywords><term xml:id="hed23235-kwd-0001">osteoporosis</term><term xml:id="hed23235-kwd-0002">alendronate</term><term xml:id="hed23235-kwd-0003">ONJ</term><term xml:id="hed23235-kwd-0004">CTX</term><term xml:id="hed23235-kwd-0005">BSAP</term></keywords><keywords rend="articleCategory"><term>Original Article</term></keywords><keywords rend="tocHeading1"><term>Original Articles</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/C2C0B6B18F602D840DB14B1C94225B43303DF96E/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en" xml:id="hed23235"><header><publicationMeta level="product"><doi origin="wiley" registered="yes">10.1002/(ISSN)1097-0347</doi><issn type="print">1043-3074</issn><issn type="electronic">1097-0347</issn><idGroup><id type="product" value="HED"></id></idGroup><titleGroup><title type="main" sort="HEAD AND NECK">Head & Neck</title><title type="short">Head Neck</title></titleGroup></publicationMeta><publicationMeta level="part" position="120"><doi>10.1002/hed.v35.12</doi><copyright ownership="publisher">Copyright © 2013 Wiley Periodicals, Inc., A Wiley Company</copyright><numberingGroup><numbering type="journalVolume" number="35">35</numbering><numbering type="journalIssue">12</numbering></numberingGroup><coverDate startDate="2013-12">December 2013</coverDate></publicationMeta><publicationMeta level="unit" position="170" type="article" status="forIssue"><doi>10.1002/hed.23235</doi><idGroup><id type="unit" value="HED23235"></id></idGroup><countGroup><count type="pageTotal" number="9"></count></countGroup><titleGroup><title type="articleCategory">Original Article</title><title type="tocHeading1">Original Articles</title></titleGroup><copyright ownership="publisher">Copyright © 2013 Wiley Periodicals, Inc., A Wiley Company</copyright><eventGroup><event type="manuscriptAccepted" date="2012-11-30"></event><event type="xmlCreated" agent="Cenveo Publisher Services" date="2013-11-13"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.3.1 mode:FullText" date="2014-05-21"></event><event type="publishedOnlineEarlyUnpaginated" date="2013-03-18"></event><event type="publishedOnlineFinalForm" date="2013-11-14"></event><event type="firstOnline" date="2013-03-18"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.6.4 mode:FullText" date="2015-10-01"></event></eventGroup><numberingGroup><numbering type="pageFirst">1787</numbering><numbering type="pageLast">1795</numbering></numberingGroup><correspondenceTo><b>Corresponding author</b>: S.‐H. Kok, Department of Dentistry, National Taiwan University Hospital, Taipei, Taiwan 10016. E‐mail: <email>shkok@ntu.edu.tw</email></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:HED.HED23235.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main">Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study</title><title type="short">Prognostic Factors of Alendronate‐Related Osteonecrosis of Jaws</title></titleGroup><creators><creator affiliationRef="#hed23235-aff-0001" creatorRole="author" xml:id="hed23235-cr-0001"><personName><givenNames>Jang‐Jaer</givenNames><familyName>Lee</familyName><degrees>DDS, MS</degrees></personName></creator><creator affiliationRef="#hed23235-aff-0001" creatorRole="author" xml:id="hed23235-cr-0002"><personName><givenNames>Shih‐Jung</givenNames><familyName>Cheng</familyName><degrees>DDS, MS, PhD</degrees></personName></creator><creator affiliationRef="#hed23235-aff-0002" creatorRole="author" xml:id="hed23235-cr-0003"><personName><givenNames>Jai‐Jen</givenNames><familyName>Wang</familyName><degrees>BA, MA, PhD</degrees></personName></creator><creator affiliationRef="#hed23235-aff-0003" creatorRole="author" xml:id="hed23235-cr-0004"><personName><givenNames>Chun‐Pin</givenNames><familyName>Chiang</familyName><degrees>DDS, DMSc</degrees></personName></creator><creator affiliationRef="#hed23235-aff-0001" creatorRole="author" xml:id="hed23235-cr-0005"><personName><givenNames>Hao‐Hueng</givenNames><familyName>Chang</familyName><degrees>DDS, MS, PhD</degrees></personName></creator><creator affiliationRef="#hed23235-aff-0001" creatorRole="author" xml:id="hed23235-cr-0006"><personName><givenNames>Hsin‐Ming</givenNames><familyName>Chen</familyName><degrees>DDS, MS, PhD</degrees></personName></creator><creator affiliationRef="#hed23235-aff-0001" corresponding="yes" creatorRole="author" xml:id="hed23235-cr-0007"><personName><givenNames>Sang‐Heng</givenNames><familyName>Kok</familyName><degrees>DDS, PhD</degrees></personName></creator></creators><affiliationGroup><affiliation type="organization" xml:id="hed23235-aff-0001" countryCode="TW"><orgDiv>School of Dentistry</orgDiv><orgName>National Taiwan University Medical Center</orgName><address><city>Taipei</city><country>Taiwan</country></address></affiliation><affiliation type="organization" xml:id="hed23235-aff-0002" countryCode="TW"><orgDiv>Department of Finance</orgDiv><orgName>Feng Chia University</orgName><address><city>Taichung</city><country>Taiwan</country></address></affiliation><affiliation type="organization" xml:id="hed23235-aff-0003" countryCode="TW"><orgDiv>Graduate Institute of Oral Biology</orgDiv><orgDiv>School of Dentistry</orgDiv><orgName>National Taiwan University Medical Center</orgName><address><city>Taipei</city><country>Taiwan</country></address></affiliation></affiliationGroup><keywordGroup type="author"><keyword xml:id="hed23235-kwd-0001">osteoporosis</keyword><keyword xml:id="hed23235-kwd-0002">alendronate</keyword><keyword xml:id="hed23235-kwd-0003">ONJ</keyword><keyword xml:id="hed23235-kwd-0004">CTX</keyword><keyword xml:id="hed23235-kwd-0005">BSAP</keyword></keywordGroup><abstractGroup><abstract type="main"><section xml:id="hed23235-sec-0001"><title type="main">Background</title><p>Studies concerning prognostic factors specific for alendronate‐related osteonecrosis of the jaws (ONJ) are rare.</p></section><section xml:id="hed23235-sec-0002"><title type="main">Methods</title><p>We surveyed a cohort of 100 osteoporotic patients with 111 alendronate‐related ONJ lesions treated during a 4‐year period. Prognostic values of clinical variables and serum markers of bone turnover were assessed by univariate and multivariate analyses.</p></section><section xml:id="hed23235-sec-0003"><title type="main">Results</title><p>The cumulative complete response rate at 6 months was 48.65%. Serum bone‐specific alkaline phosphatase (BSAP) level >10 μg/L, lesion depth ≦ 10 mm, and lesions in anterior regions denoted a better chance of healing within 6 months and the adjusted hazard ratios were 2.48 (95% confidence interval [CI], 1.41–4.37), 2.71 (95% CI, 1.57–4.70), and 3.94 (95% CI, 1.87–8.30), respectively.</p></section><section xml:id="hed23235-sec-0004"><title type="main">Conclusions</title><p>Early discovery of lesions and prevention of their deeper extension are crucial for improving the prognosis of alendronate‐related ONJ. A higher pretreatment level of BSAP indicates a better prognosis. © 2013 Wiley Periodicals, Inc. <i>Head Neck</i> 35: 1787–1795, 2013</p></section></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Prognostic Factors of Alendronate‐Related Osteonecrosis of Jaws</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study</title></titleInfo><name type="personal"><namePart type="given">Jang‐Jaer</namePart><namePart type="family">Lee</namePart><namePart type="termsOfAddress">DDS, MS</namePart><affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Shih‐Jung</namePart><namePart type="family">Cheng</namePart><namePart type="termsOfAddress">DDS, MS, PhD</namePart><affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Jai‐Jen</namePart><namePart type="family">Wang</namePart><namePart type="termsOfAddress">BA, MA, PhD</namePart><affiliation>Department of Finance, Feng Chia University, Taichung, Taiwan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Chun‐Pin</namePart><namePart type="family">Chiang</namePart><namePart type="termsOfAddress">DDS, DMSc</namePart><affiliation>Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Hao‐Hueng</namePart><namePart type="family">Chang</namePart><namePart type="termsOfAddress">DDS, MS, PhD</namePart><affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Hsin‐Ming</namePart><namePart type="family">Chen</namePart><namePart type="termsOfAddress">DDS, MS, PhD</namePart><affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Sang‐Heng</namePart><namePart type="family">Kok</namePart><namePart type="termsOfAddress">DDS, PhD</namePart><affiliation>School of Dentistry, National Taiwan University Medical Center, Taipei, Taiwan</affiliation><affiliation>E-mail: shkok@ntu.edu.tw</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><dateIssued encoding="w3cdtf">2013-12</dateIssued><dateCreated encoding="w3cdtf">2013-11-13</dateCreated><dateValid encoding="w3cdtf">2012-11-30</dateValid><copyrightDate encoding="w3cdtf">2013</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><abstract>Studies concerning prognostic factors specific for alendronate‐related osteonecrosis of the jaws (ONJ) are rare.</abstract><abstract>We surveyed a cohort of 100 osteoporotic patients with 111 alendronate‐related ONJ lesions treated during a 4‐year period. Prognostic values of clinical variables and serum markers of bone turnover were assessed by univariate and multivariate analyses.</abstract><abstract>The cumulative complete response rate at 6 months was 48.65%. Serum bone‐specific alkaline phosphatase (BSAP) level >10 μg/L, lesion depth ≦ 10 mm, and lesions in anterior regions denoted a better chance of healing within 6 months and the adjusted hazard ratios were 2.48 (95% confidence interval [CI], 1.41–4.37), 2.71 (95% CI, 1.57–4.70), and 3.94 (95% CI, 1.87–8.30), respectively.</abstract><abstract>Early discovery of lesions and prevention of their deeper extension are crucial for improving the prognosis of alendronate‐related ONJ. A higher pretreatment level of BSAP indicates a better prognosis. © 2013 Wiley Periodicals, Inc. Head Neck 35: 1787–1795, 2013</abstract><subject><genre>keywords</genre><topic>osteoporosis</topic><topic>alendronate</topic><topic>ONJ</topic><topic>CTX</topic><topic>BSAP</topic></subject><relatedItem type="host"><titleInfo><title>Head & Neck</title></titleInfo><titleInfo type="abbreviated"><title>Head Neck</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>Original Article</topic></subject><identifier type="ISSN">1043-3074</identifier><identifier type="eISSN">1097-0347</identifier><identifier type="DOI">10.1002/(ISSN)1097-0347</identifier><identifier type="PublisherID">HED</identifier><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><detail type="issue"><caption>no.</caption><number>12</number></detail><extent unit="pages"><start>1787</start><end>1795</end><total>9</total></extent></part></relatedItem><identifier type="istex">C2C0B6B18F602D840DB14B1C94225B43303DF96E</identifier><identifier type="ark">ark:/67375/WNG-GM5TSDTZ-V</identifier><identifier type="DOI">10.1002/hed.23235</identifier><identifier type="ArticleID">HED23235</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2013 Wiley Periodicals, Inc., A Wiley CompanyCopyright © 2013 Wiley Periodicals, Inc., A Wiley Company</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/document/C2C0B6B18F602D840DB14B1C94225B43303DF96E/metadata/json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000740 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000740 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:C2C0B6B18F602D840DB14B1C94225B43303DF96E
|texte= Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study
}}
| This area was generated with Dilib version V0.6.33. |  |